Clinical trial
A Study of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have…
NCT00411554 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00411554 |
|---|---|
| Title | A Study of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Diet/Exercise Therapy (0431-054)(COMPLETED) |
| Official title | Sitagliptin (MK0431) Phase III Double-blind Comparative Study - Type 2 Diabetes Mellitus - |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Non-Insulin-Dependent |
| Intervention type | Drug |
| Interventions | sitagliptin phosphate, Comparator: voglibose |
| Enrollment | 319 |
| Start date | Jan 1, 2007 |
| Primary completion | Aug 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | Dec 14, 2006 |
| Last update posted | Feb 5, 2016 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: